The stock price of ) surpassed its fifty-day moving average on Wednesday during trading. The stock's fifty-day moving average is $1.16, and it has traded up to $1.25. Pharming Group's shares were last traded at $1.25 with 800 shares trading hands.
Pharming Group Stock Performance
The company's moving average is $1.20 and $1.16 for the past 50 days. The debt-to equity ratio is 0.68. Current ratios are 5.40 and 4.68. The company has a market capitalization of $813.88 millions, a P/E ratio of 31.20, and a beta value of 1.09.
Pharming Group Company profile
Pharming Group NV, a holding firm, is engaged in the development and production of pharmaceuticals for the treatment of unmet medical needs. The company offers RUCONEST which is a recombinant C1-esterase inhibitor for acute hereditary edema. The company operates in three geographical segments: the United States of America, Europe and Rest of the World.
MarketBeat.com offers a FREE daily email newsletter